Syngene International commissions R&D Center for Amgen

06 Sep 2016 Evaluate

Syngene International, has established an integrated, multi-disciplinary drug discovery and development center for Amgen, Inc., in Bangalore, India. This center, named Syngene Amgen Research and Development Center (SARC), will be company’s fourth such exclusive R&D center. The company already operates dedicated R&D centers for Bristol-Myers Squibb, Abbott Nutrition and Baxter Inc.

Syngene has partnered with Amgen in a variety of discovery and development projects. With the establishment of SARC, this association now extends into a multi-discipline collaboration spanning capabilities in medicinal and process chemistry, biologics, bioprocess, drug metabolism, pharmacokinetics, bio-analytical research and pharmaceutical development.

Syngene International is one of Asia’s largest Contract Research Organizations, offers discovery and development services for novel molecular entities (NMEs) across industrial sectors including pharmaceutical, biotechnology, agrochemicals, consumer health, animal health, cosmetic and nutrition.

Syngene Internation. Share Price

683.25 9.10 (1.35%)
18-Mar-2025 16:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 683.25
Sagility India 42.29
AGS Transact Tech 11.46
Just Dial 837.00
Krystal Integrated 428.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...